BRIVARACETAM
ANTICONVULSANTS · FOCAL EPILEPSY
AUROBINDO PHARM
Drug class
Anticonvulsant - Pyrrolidine Derivatives
Anticonvulsant pyrrolidine derivatives are a chemically defined therapeutic class of antiseizure medications, characterized by a central pyrrolidine or 2-oxopyrrolidine ring structure, exemplified by agents such as levetiracetam and brivaracetam. Read more about Anticonvulsant - Pyrrolidine Derivatives
116 drugs in this class 85 manufacturers
Drugs in Anticonvulsant - Pyrrolidine Derivatives
BRIVARACETAM
ANTICONVULSANTS · FOCAL EPILEPSY
PHARMACEU ASSOC
BRIVARACETAM
ANTICONVULSANTS · FOCAL EPILEPSY
APOTEX CORP
BRIVARACETAM
ANTICONVULSANTS · FOCAL EPILEPSY
ASCEND LABORATO
BRIVARACETAM
ANTICONVULSANTS · FOCAL EPILEPSY
LUPIN PHARMACEU
BRIVARACETAM
ANTICONVULSANTS · FOCAL EPILEPSY
FLORIDA PHARMAC
LEVETIRACETAM-NACL (levetiracetam in sodium chloride, iso-osmotic)
ANTICONVULSANTS · MYOCLONIC EPILEPSY ADJUNCT TREATMENT ·+2
Pfizer Laboratories
BRIVARACETAM
ANTICONVULSANTS · FOCAL EPILEPSY
SOLARIS PHARMA
BRIVARACETAM
ANTICONVULSANTS · FOCAL EPILEPSY
MICRO LABS USA,
Filter & compare in the drug finder →
Opens the drug finder with Anticonvulsant - Pyrrolidine Derivatives preselected. Add indication or manufacturer filters there.
Anticonvulsant pyrrolidine derivatives are a chemically defined therapeutic class of antiseizure medications, characterized by a central pyrrolidine or 2-oxopyrrolidine ring structure, exemplified by agents such as levetiracetam and brivaracetam.
Their primary mechanism of action involves high-affinity binding to synaptic vesicle protein 2A (SV2A) in the central nervous system, which modulates presynaptic vesicle exocytosis and reduces excessive, synchronized neurotransmitter release.
Clinically, these agents are utilized for the management of epilepsy disorders, serving as monotherapy or adjunctive therapy for partial-onset (focal) seizures as well as generalized tonic-clonic and myoclonic seizures.
-
google.com
Anticonvulsant pyrrolidine derivatives are a chemically defined therapeutic class of antiseizure medications, characterized by a central pyrrolidine or 2-oxopyrrolidine ring structure, exemplified by agents such as levetiracetam and brivaracetam Clinically, these agents are utilized for the management of epilepsy disorders, serving as monotherapy or adjunctive therapy for partial-onset (focal) seizures as well as generalized tonic-clonic and myoclonic seizures
-
paragraphfour.com
Anticonvulsant pyrrolidine derivatives are a chemically defined therapeutic class of antiseizure medications, characterized by a central pyrrolidine or 2-oxopyrrolidine ring structure, exemplified by agents such as levetiracetam and brivaracetam
-
nih.gov
Anticonvulsant pyrrolidine derivatives are a chemically defined therapeutic class of antiseizure medications, characterized by a central pyrrolidine or 2-oxopyrrolidine ring structure, exemplified by agents such as levetiracetam and brivaracetam Their primary mechanism of action involves high-affinity binding to synaptic vesicle protein 2A (SV2A) in the central nervous system, which modulates presynaptic vesicle exocytosis and reduces excessive, synchronized neurotransmitter release Clinically, ...
-
nih.gov
Their primary mechanism of action involves high-affinity binding to synaptic vesicle protein 2A (SV2A) in the central nervous system, which modulates presynaptic vesicle exocytosis and reduces excessive, synchronized neurotransmitter release
-
nih.gov
Their primary mechanism of action involves high-affinity binding to synaptic vesicle protein 2A (SV2A) in the central nervous system, which modulates presynaptic vesicle exocytosis and reduces excessive, synchronized neurotransmitter release
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.